Activators of peroxisome proliferator-activated receptors
AssigneesKowa Company, Ltd., Nagasaki Prefectural and Municipal Universities Corporation
InventorsYoshihiro Shidoji, Naoto Ishibashi
Life of this patent
Estimating the term…
Abstract
Activators of peroxisome proliferator-activated receptors comprising a polyprenyl compound, preferably (2E,4E,6E,10E)-3,7,11,15-tetramethyl-2,4,6,10,14-hexadecapentaenoic acid, as an active ingredient, and medicaments for preventive and/or therapeutic treatment of hyperlipidemia, non-insulin dependent diabetes mellitus or the like comprising a polyprenyl compound as an active ingredient.
Claims3
A method of treating non-insulin dependent diabetes mellitus, wherein the method comprises administering a therapeutically effective amount of at least one polyprenyl compound to a patient in need thereof, the at least one polyprenyl compound comprising 3,7,11,15-tetramethyl-2,4,6,10,14-hexadecapentaenoic acid.
Dependencies are inferred from the claim text.